Monitoring time & cost burden of DMTs on MS services

The Neurology Academy is seeking to raise awareness of the time and cost of monitoring disease modifying drugs (DMD) and as part of its strategic plan has developed a DMD monitoring tool to enable units to assess how long it takes to monitor patients currently receiving treatment.

Perhaps one of the less visible services we provide as part of the MasterClass programme is service redesign and integrated care pathway development. → More information here